Page last updated: 2024-09-02

valerates and Disbacteriosis

valerates has been researched along with Disbacteriosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, YE; Cheng, S; Garcia-Barrio, MT; Guo, X; He, Y; Huang, W; Ji, L; Liu, Z; Meng, X; Pan, B; Wang, L; Xiong, X; Xu, M; Yang, H; Yin, Y; Zhao, L; Zhao, M; Zheng, L	1
Duan, Y; Gao, J; Guo, Q; Han, H; Kong, X; Li, F; Li, T; Li, Y; Song, B; Wang, W; Xiao, H; Xu, K; Yin, J; Yin, Y; Zheng, C; Zhong, Y	1

Other Studies

2 other study(ies) available for valerates and Disbacteriosis

Article	Year
TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice. Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bacteria; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Diet, High-Fat; Dysbiosis; Fatty Acids, Nonesterified; Feces; Female; gamma-Butyrobetaine Dioxygenase; Gastrointestinal Microbiome; Humans; Intestines; Lipolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Up-Regulation; Valerates; Young Adult	2020
Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:9 Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Bacteroidetes; Diet, High-Fat; Dysbiosis; Fatty Acids, Volatile; Fecal Microbiota Transplantation; Firmicutes; Gastrointestinal Microbiome; Gene Expression Profiling; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred ICR; Obesity; Propionates; Random Allocation; RNA, Messenger; Valerates	2019

Article

Year

TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.

Gastroenterology, 2020, Volume: 158, Issue:8

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bacteria; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Diet, High-Fat; Dysbiosis; Fatty Acids, Nonesterified; Feces; Female; gamma-Butyrobetaine Dioxygenase; Gastrointestinal Microbiome; Humans; Intestines; Lipolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Up-Regulation; Valerates; Young Adult

2020

Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:9

Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Bacteroidetes; Diet, High-Fat; Dysbiosis; Fatty Acids, Volatile; Fecal Microbiota Transplantation; Firmicutes; Gastrointestinal Microbiome; Gene Expression Profiling; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred ICR; Obesity; Propionates; Random Allocation; RNA, Messenger; Valerates

2019